TapImmune Inc (NASDAQ:TPIV)

3.44
Delayed Data
As of May 22
 -0.20 / -5.49%
Today’s Change
2.58
Today|||52-Week Range
4.41
-12.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses2.4M4.2M2.7M3.2M
 
 
 
 
 
Research And Development1.2M1.6M1.4M1.6M
 
 
 
 
 
Total Operating Expenses2.4M4.2M2.7M3.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.4M-4.2M-2.7M-3.2M
 
 
 
 
 
Extraordinary Credit499.9K4.0K0.001.0K
 
 
 
 
Extraordinary Charge0.000.00-3.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-4.0M-2.7M-3.2M
 
 
 
 
 
Net Income-1.9M-4.0M-2.7M-3.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.6M10.2M10.6M10.6M
 
 
 
 
 
Shares To Calculate EPS Diluted8.6M10.2M10.6M10.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.39-$0.25-$0.30
 
 
 
 
 
EPS Diluted-$0.22-$0.39-$0.25-$0.30